Gangwal Healthcare
Generated 5/24/2026
Executive Summary
Gangwal Healthcare Pvt Ltd is an Indian contract manufacturing organization (CMO) specializing in pharmaceuticals, nutraceuticals, transdermal patches, and orally dissolving films. Founded in 2021 and based in Tarapur, the company leverages advanced manufacturing facilities and high-quality excipients to offer end-to-end formulation development and scalable production services to global health brands. With an employee range of 200–500 and a commercial-stage focus, Gangwal Healthcare is positioned to capitalize on the growing demand for outsourced manufacturing in the pharma and nutraceutical sectors. Its expertise in niche drug delivery technologies such as transdermal patches and orally dissolving films provides a competitive edge, as these modalities are increasingly sought after for improved patient compliance and targeted therapy. The company's private status and recent founding suggest a growth trajectory driven by operational excellence and strategic partnerships, though public financial details and pipeline data remain limited.
Upcoming Catalysts (preview)
- Q2 2026Expansion of manufacturing capacity or new facility70% success
- Q3 2026Partnership with a global health brand for transdermal patch production60% success
- Q4 2026Regulatory approval for orally dissolving film product55% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)